An Examination of the Mechanisms Involved in Secondary Clinical Failure to Adalimumab or Etanercept in Inflammatory Arthropathies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Examination of the Mechanisms Involved in Secondary Clinical Failure to Adalimumab or Etanercept in Inflammatory Arthropathies

Published:2015-04 Issue:3 Volume:21 Page:115-119
ISSN:1076-1608
Container-title:JCR Journal of Clinical Rheumatology
language:en
Short-container-title:JCR Journal of Clinical Rheumatology

Author:

Bandrés Ciga Sara,Salvatierra Juan,López-Sidro Mar,García-Sánchez Antonio,Durán Raquel,Vives Francisco,Raya-Álvarez Enrique

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rheumatology

Reference26 articles.

1. Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis

2. The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review

3. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

4. Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Correlation between Anti-drug Antibodies and Therapeutic Response in Tunisian Patients with Chronic Inflammatory Diseases Treated by TNF Blockers;Current Rheumatology Reviews;2024-09

2. Next-Generation Anti-TNFα Agents: The Example of Ozoralizumab;BioDrugs;2024-04-08

3. Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review;Modern Rheumatology;2023-04-06

4. Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition;Advances in Therapy;2022-02-24

5. Anti-TROVE2 Antibody Determined by Immune-Related Array May Serve as a Predictive Marker for Adalimumab Immunogenicity and Effectiveness in RA;Journal of Immunology Research;2021-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3